News>Biocon shares

Biocon shares

Advertisement

Biocon falls nearly 6% on USFDA observations for Bengaluru facility

Biocon shares
Biocon surges 14% on USFDA nod for biosimilar of cancer drug
Biocon surges 14% on USFDA nod for biosimilar of cancer drug
Biocon stocks gain over 5%, hit 52-week high in intra-day trade
Biocon stocks gain over 5%, hit 52-week high in intra-day trade
Biocon shares end higher as arm Syngene gets Sebi nod for IPO
Biocon shares end higher as arm Syngene gets Sebi nod for IPO
Biocon shares gain 3% as arm Syngene gets Sebi nod for IPO
Biocon shares gain 3% as arm Syngene gets Sebi nod for IPO
NEWS ON ONE CLICK